Davis-Jewish General Hospital. He joined the Department of Oncology in 2002 after completing a Postdoctoral Fellowship at the MD Anderson Cancer Center, the University of Texas, in Houston, Texas where he was involved in clinical studies of a farnesyl transferase inhibitor. His research interests are Clinical trials; Molecularly-targeted therapy; Cancer prevention and Lung cancer.